Overview
Study information
| Network: | CAVD |
| Grant Affiliation: | Pantaleo: Poxvirus-Based Vaccine Development |
| Strategy: | Combo: DNA, protein & vector vaccines |
| Study Type: | Pre-Clinical NHP |
| Species: | Rhesus macaque |
| Stage: | Assays Completed |
| Study Start Date: | 2010-11-16 |
| Study Made Public: | 2013-08-16 |
Title
Evaluate and compare immunogenicity and safety of the highly attenuated replication competent NYVAC-C-KC vs. replication incompetent NYVAC-C in the vaccination combination with DNA and protein
Description
CAVD 259 (AUP444/CAVIMC-033) is a non-human primate study comparing 5 different prime/boost regimens of NYVAC-C-KC or NYVAC-C in combination with DNA-C, protein, and MF59.
Sign in to see full information about this study and to download study data.
Products
NYVAC-C-KC NYVAC-C (vP2010) MF59 DNA-C HIV-1 C EnvIntegrated data
BAMA, ICS, ELISpot, NAb
Non-integrated data
No non-integrated data is available for this study.